Skip to main content
GutCited

Mô tả

Laboratory safety parameters monitored during the GutGard trial are reported, confirming no significant adverse changes in hepatic or renal function markers during the 30-day treatment period.

Cite This Figure

![Figure 11: Laboratory safety parameters monitored during the GutGard trial are reported, confirming no significant adverse changes in hepatic or renal function markers during the 30-day treatment period.]()

> Source: Kadur Ramamurthy Raveendra et al. "An Extract of Glycyrrhiza glabra (GutGard) Alleviates Symptoms of Functional Dys." *Evidence-based complementary and alternative medicine : eCAM*, 2012. PMID: [21747893](https://pubmed.ncbi.nlm.nih.gov/21747893/)
<figure>
  <img src="" alt="Laboratory safety parameters monitored during the GutGard trial are reported, confirming no significant adverse changes in hepatic or renal function markers during the 30-day treatment period." />
  <figcaption>Figure 11. Laboratory safety parameters monitored during the GutGard trial are reported, confirming no significant adverse changes in hepatic or renal function markers during the 30-day treatment period.<br>  Source: Kadur Ramamurthy Raveendra et al. "An Extract of Glycyrrhiza glabra (GutGard) Alleviates Symptoms of Functional Dys." <em>Evidence-based complementary and alternative medicine : eCAM</em>, 2012. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/21747893/">21747893</a></figcaption>
</figure>